News

Each Rare Cancer Accounts for less than 40,000 new cases each year.

Targeting Prevention to Reduce the High Human Toll of Rare Cancers

POSTED: October 1, 2024
SOURCE: Cancer Prevention Science Blog

At the Rare Cancers Prevention and Interception workshop this year, cancer researchers from across the United States, Canada, and the United Kingdom and from across disciplines sought to address many of the issues that can…
Histological slide (H & E stain at x300) showing prostate cancer.
Early Detection Research Network Marks 20 Years
This month, the Early Detection Research Network (EDRN) marks its 20th anniversary. The National Cancer Institute (NCI) launched the network in 2000 with the goal of identifying and harnessing biomarkers as a way of detecting cancer at earlier stages. Today, the network comprises more than 300… Learn more
POSTED: 12/21/2020
SOURCE: AACR Cancer Research Cataylst Blog
Scientific Achievements During 2020: An Unforgettable Year of Progress in the NCI Division of Cancer Prevention
DCP Director Philip E. Castle, Ph.D., M.P.H. As this unforgettable year of 2020 comes to an end, I am reaching the milestone of my first 6 months as Director of the NCI Division of Cancer Prevention (DCP). It has been a whirlwind of virtual meetings and… Learn more
POSTED: 12/17/2020
SOURCE: Cancer Prevention Science Blog
AUTHOR: Philip E. Castle, Ph.D., M.P.H.
Portraits of Principal investigators Katherine D. Crew, M.D., M.S., (left) and Rita Kukafka, Dr.P.H., M.A. (right)
Making Informed Choices on Incorporating Chemoprevention Into Breast Care: Q & A with Dr. Katherine Crew on the MiCHOICE Trial
The SWOG Cancer Research Network is opening to accrual the MiCHOICE Trial to study the use of decision support tools by women with high-risk breast conditions and their healthcare providers to choose among chemoprevention… Learn more
POSTED: 12/8/2020
SOURCE: Cancer Prevention Science Blog
Image of clinician's hands typing on laptop on office desk from above.
How Patients and Their Doctors Determine Cancer Risk—and What Happens Next
If you were concerned that you might be at increased risk for a specific kind of cancer, what would you do to confirm that risk, and what would you be willing to do to reduce that risk? The answer is likely to be, "it depends on your doctor." Quotes from Focus Group Participants "The claim of… Learn more
POSTED: 11/19/2020
SOURCE: Cancer Prevention Science Blog
AUTHOR: Goli Samimi, Ph.D., M.P.H.
Some Clinical Trials Changes due to COVID-19 Proposed for Long-term Use by NCI Leaders
In a commentary written by several of its clinical scientific leaders, changes were proposed to the National Cancer Institute (NCI) clinical trials program to improve clinical trial availability, effectiveness, and diversity. The article, “COVID-19, Social Justice, and Clinical Cancer Research,”… Learn more
POSTED: 11/16/2020
SOURCE: DCP News
An image of healthy foods, including vegetables, nuts, and eggs.
Nutrition Frontiers - Fall 2020
This issue reveals a metaproteomic approach to assessing the gut microbiome, genestein’s effect on remodeling pathways to suppress kidney cancer, and neferine from lotus seeds pro-oxidant anticancer mechanisms. Meet our… Learn more
POSTED: 10/29/2020
SOURCE: DCP News
A side-by-side of two normal mammograms showing the difference between a dense breast (left) and a fatty breast (right).
Projects Making Progress in Breast Cancer Detection and Prevention
DCP Director Philip E. Castle, Ph.D., M.P.H. In the month of October, breast cancer awareness is the health message that looms large. Yet, researchers across the National Cancer Institute and across the world are focused on breast cancer all the time.… Learn more
POSTED: 10/19/2020
SOURCE: Cancer Prevention Science Blog
AUTHOR: Philip E. Castle, Ph.D., M.P.H.
Photo of a cancer patient.
NCI Cancer Moonshot℠ Biobank Launches Exclusively through 20 NCORP Sites
NCI has launched the Cancer Moonshot℠ Biobank to procure and distribute longitudinal patient biospecimens for cancer research exclusively through 20 community research sites in the NCI Community Oncology Research Program (NCORP). Both the biobank pilot study, "NCORP Tissue Procurement Protocol: An… Learn more
POSTED: 10/19/2020
SOURCE: NCI DCTD News
NCI Announces SeroNet Collaboration: Division of Cancer Prevention Supports Six of These Critical SARS-CoV-2-Focused Grants
The National Cancer Institute was directed by Congress "to develop, validate, improve, and implement serological testing and associated technologies" to characterize the immune responses elicited by SARS-CoV-2 viral infection. As part of the response, the institute established Serological Sciences… Learn more
POSTED: 10/8/2020
SOURCE: DCP News